Extracorporeal membrane oxygenation in cardiopulmonary disease in adults

Darryl Abrams; Alain Combes; Daniel Brodie

doi:10.1016/j.jacc.2014.03.046

Extracorporeal membrane oxygenation in cardiopulmonary disease in adults

J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2769-78. doi: 10.1016/j.jacc.2014.03.046. Epub 2014 May 7.

Authors

Darryl Abrams¹, Alain Combes², Daniel Brodie³

Affiliations

¹ Division of Pulmonary, Allergy, and Critical Care, Columbia University College of Physicians and Surgeons, New York, New York.
² Service de Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière, Institute of Cardiometabolism and Nutrition, Assistance Publique-Hôpitaux de Paris-Université Pierre et Marie Curie, Paris, France.
³ Division of Pulmonary, Allergy, and Critical Care, Columbia University College of Physicians and Surgeons, New York, New York. Electronic address: hdb5@cumc.columbia.edu.

PMID: 24814488
DOI: 10.1016/j.jacc.2014.03.046

Abstract

The use of extracorporeal membrane oxygenation (ECMO) for both respiratory and cardiac failure in adults is evolving rapidly. Advances in technology and accumulating data are spurring greater interest and explosive growth in ECMO worldwide. Expanding indications and novel strategies are being used. Yet the use of ECMO outpaces the data. The promise of a major paradigm shift for the treatment of respiratory and cardiac failure is tempered by a need for evidence to support many current and potential future uses. The authors review cannulation strategies, indications, and evidence for ECMO in respiratory and cardiac failure in adults as well as potential applications and the impact they may have on current treatment paradigms.

Keywords: ARDS; cardiogenic shock; extracorporeal membrane oxygenation; heart failure; respiratory failure.

Publication types

Review

MeSH terms

Adult
Extracorporeal Membrane Oxygenation / methods*
Heart Failure / therapy*
Humans
Respiratory Insufficiency / therapy*
Treatment Outcome